4//SEC Filing
O'Dowd Hugh 4
Accession 0001694187-20-000007
CIK 0001694187other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 5:20 PM ET
Size
5.1 KB
Accession
0001694187-20-000007
Insider Transaction Report
Form 4
O'Dowd Hugh
DirectorPresident & CEO
Transactions
- Award
Common Stock
2020-01-12+240,000→ 785,868 total
Footnotes (1)
- [F1]Mr. O'Dowd was awarded 240,000 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. The Restricted Stock Units shall vest annually over three years, with one-third vesting on January 31, 2021 and the balance vesting in two equal annual installments thereafter, subject to the Reporting Person's continued service. The Restricted Stock Units may be settled only by delivering shares of Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
Documents
Issuer
Neon Therapeutics, Inc.
CIK 0001694187
Entity typeother
Related Parties
1- filerCIK 0001741171
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 5:20 PM ET
- Size
- 5.1 KB